🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study investigated a 4-week adjunctive therapy of either a GLP-1 analo...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2008-01
Trial ID
NCT00971659
Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Status
Unknown
Location
Kurume University Hospital
Start Date
2015-08
Trial ID
NCT02528019
Treatments Being Tested
The study is a multicenter, prospective, open-label, randomized pilot study...
Status
Completed
Location
Grady Memorial Hospital
Start Date
2011-08
Trial ID
NCT01378117
Treatments Being Tested
The purpose of this study is to determine whether the dipeptidyl peptidase ...
Status
Terminated
Location
University of British Columbia Gerontology & Diabetes Reserach Centre (ViTALITY)
Start Date
2010-09
Trial ID
NCT01257464
Treatments Being Tested
This study evaluate the effect of dipeptidyl-peptidase 4 inhibitor on vascu...
Status
Unknown
Location
Keimyung University Hospital
Start Date
2016-06
Trial ID
NCT02802644
Treatments Being Tested
Incretinomimetics and inhibitors of dipeptidyl peptidase-4 (DPP-4) are new ...
Status
Terminated
Location
Gastroenterology Department Erasme Hospital
Start Date
2014-10
Trial ID
NCT02244164
Treatments Being Tested
Our trial goal is to determine the efficacy and safety of sitagliptin in co...
Status
Completed
Location
University of Sadat City
Start Date
2020-09-20
Trial ID
NCT05359341
There are recent advances in therapies for the treatment of Type 2 Diabetes...
Status
Completed
Location
University Hospitals of Leicester NHS Trust, Diabetes Research Centre
Start Date
2013-12-16
Trial ID
NCT02043054
Treatments Being Tested
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
The study purpose is to assess adverse events in patients with Type 2 diabe...
Status
Terminated
Location
Local Institution
Start Date
2013-10
Trial ID
NCT01944618
Treatments Being Tested